Inogen, Inc. (INGN)Healthcare | Medical Devices | Beverly, United States | NasdaqGS
6.82 USD
+0.23
(3.490%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 6.82 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:26 p.m. EDT
INGN is a highly volatile stock with significant short-term risks. The recent price history shows a lack of consistent upward momentum, and the fundamentals are weak, with negative profit margins and a low forward PE. The stock has experienced substantial losses over the past five years, and there is no dividend history to provide income. While there is some options activity, it is not enough to signal a strong buying opportunity. Long-term investors should be cautious, as the fundamentals do not support a buy-and-hold strategy. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.054512 |
| MSTL | 0.060686 |
| AutoTheta | 0.076902 |
| AutoARIMA | 0.144238 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 11.54 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.572 |
| Excess Kurtosis | -0.75 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.091 |
| Revenue per Share | 13.107 |
| Market Cap | 185,724,624 |
| Forward P/E | -22.00 |
| Beta | 1.71 |
| Profit Margins | -6.52% |
| Website | https://www.provider.inogen.com |
As of April 11, 2026, 1:26 p.m. EDT: Options speculators are showing mixed signals. Calls are showing some activity, particularly around the 7.5 strike price, with increased volume and open interest. However, the puts are also showing significant activity, especially around the 5.0 strike price, indicating potential bearish sentiment. The high implied volatility for some expirations suggests uncertainty about the future price direction. Overall, the options market is indicating a cautious approach, with both bullish and bearish positions present.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.011869431 |
| Address1 | 500 Cummings Center |
| Address2 | Suite 2800 |
| All Time High | 287.79 |
| All Time Low | 4.13 |
| Ask | 6.87 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 350,860 |
| Average Daily Volume3 Month | 291,417 |
| Average Volume | 291,417 |
| Average Volume10Days | 350,860 |
| Beta | 1.705 |
| Bid | 6.77 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 7.059 |
| City | Beverly |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 3 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.82 |
| Current Ratio | 3.121 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.92 |
| Day Low | 6.6193 |
| Debt To Equity | 9.091 |
| Display Name | Inogen |
| Earnings Call Timestamp End | 1,771,970,400 |
| Earnings Call Timestamp Start | 1,771,970,400 |
| Earnings Timestamp | 1,771,966,800 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | -9,548,000 |
| Ebitda Margins | -0.027379999 |
| Enterprise To Ebitda | -8.758 |
| Enterprise To Revenue | 0.24 |
| Enterprise Value | 83,623,624 |
| Eps Current Year | -0.52 |
| Eps Forward | -0.31 |
| Eps Trailing Twelve Months | -0.86 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.1766 |
| Fifty Day Average Change | 0.6434002 |
| Fifty Day Average Change Percent | 0.10416737 |
| Fifty Two Week Change Percent | 1.186943 |
| Fifty Two Week High | 9.13 |
| Fifty Two Week High Change | -2.31 |
| Fifty Two Week High Change Percent | -0.25301203 |
| Fifty Two Week Low | 5.34 |
| Fifty Two Week Low Change | 1.48 |
| Fifty Two Week Low Change Percent | 0.27715355 |
| Fifty Two Week Range | 5.34 - 9.13 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,392,388,200,000 |
| Float Shares | 24,033,638 |
| Forward Eps | -0.31 |
| Forward P E | -22.0 |
| Free Cashflow | -21,157,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 753 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.44244 |
| Gross Profits | 154,264,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.119729996 |
| Held Percent Institutions | 0.76657 |
| Implied Shares Outstanding | 27,232,350 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts. |
| Long Name | Inogen, Inc. |
| Market | us_market |
| Market Cap | 185,724,624 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_7701753 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -22,747,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 185,452,303 |
| Number Of Analyst Opinions | 3 |
| Open | 6.64 |
| Operating Cashflow | -11,216,000 |
| Operating Margins | -0.12205 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 805 562 0500 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 6.82 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 6.59 |
| Price Eps Current Year | -13.115385 |
| Price Hint | 2 |
| Price To Book | 0.96614254 |
| Price To Sales Trailing12 Months | 0.53266895 |
| Profit Margins | -0.06524 |
| Quick Ratio | 2.517 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.23 |
| Regular Market Change Percent | 3.49014 |
| Regular Market Day High | 6.92 |
| Regular Market Day Low | 6.6193 |
| Regular Market Day Range | 6.6193 - 6.92 |
| Regular Market Open | 6.64 |
| Regular Market Previous Close | 6.59 |
| Regular Market Price | 6.82 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 275,982 |
| Return On Assets | -0.06348 |
| Return On Equity | -0.12427 |
| Revenue Growth | 0.02 |
| Revenue Per Share | 13.107 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 27,232,350 |
| Shares Percent Shares Out | 0.041199997 |
| Shares Short | 1,120,713 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,208,558 |
| Short Name | Inogen, Inc |
| Short Percent Of Float | 0.0416 |
| Short Ratio | 4.29 |
| Source Interval | 15 |
| State | MA |
| Symbol | INGN |
| Target High Price | 14.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 12.66667 |
| Target Median Price | 12.0 |
| Total Cash | 119,577,000 |
| Total Cash Per Share | 4.391 |
| Total Debt | 17,476,000 |
| Total Revenue | 348,668,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.86 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.02855 |
| Two Hundred Day Average Change | -0.20854998 |
| Two Hundred Day Average Change Percent | -0.029671835 |
| Type Disp | Equity |
| Volume | 275,982 |
| Website | https://www.provider.inogen.com |
| Zip | 1,915 |